Among the cases of visceral artery aneurysms, those that involve the inferior mesenteric artery are the most uncommon, with a prevalence of <1%. This study reports a giant symptomatic inferior mesenteric artery aneurysm and its endovascular treatment by means of percutaneous embolization with the implantation of pushable coils. After complete occlusion of the aneurysm, adequate maintenance of arterial supply of the left colon and resolution of the symptoms were observed. In the 2-year follow-up, a significant reduction in the aneurysm's volume and maintenance of the clinical condition were observed. (J Vasc Surg Cases and Innovative Techniques 2018;4:315-8 Open repair with IMA resection and reimplantation has been considered the standard treatment, especially in cases in which maintenance of arterial supply by this vessel is mandatory, as in stenosis or superior mesenteric artery occlusion (high-flow aneurysms). 6 In turn, when the risks of a transperitoneal surgical approach are high, with the possibility of injury to adjacent structures, endovascular treatment may be an option. However, it is necessary to make sure that colonic perfusion can be adequately supplied by the Riolan arc and the marginal artery of Drummond. 7 Embolization with the implantation of coils into the lumen of the aneurysm is one possible treatment; however, a covered stent, provided it is adequately sized for the ostial caliber and extension of the IMA, is an option that preserves intestinal flow. Liquid agents may lead to inadvertent distal embolization, which is why their use is limited. Few cases of endovascular treatment have been described for IMAA to date. The objective of the study was to report a rare case of a carrier of multiple visceral aneurysms, one of which was a giant and symptomatic IMAA that was treated by transarterial embolization, and the long-term outcome. Written informed consent to publish the case and images was obtained from the patient. This report was approved by the research ethics committee of the Faculty of Medicine of Itajubá/Brazil, registered under Plataforma Brasil (No. 043567/2017).
Visceral artery aneurysms (VAAs) develop in vessels that perfuse the intra-abdominal organs, such as the superior mesenteric artery, inferior mesenteric artery (IMA), celiac trunk, gastroduodenal artery, and splenic artery, 1 and have a prevalence of 0.1% to 2% in the general population. 2 Of these, 25% may progress to rupture, which may have mortality rates of 25% to 70%. 3 IMA aneurysm (IMAA) is a rare condition in relation to other VAAs, with an estimated prevalence of 1% of all VAAs. 4 IMAAs may be associated more commonly with atherosclerotic degeneration but also with other rarer causes. Given the low prevalence of IMAAs, there is no standardized treatment. In general, asymptomatic VAAs larger than 2 cm in diameter and symptomatic VAAs or those that evolve rapidly in size require intervention. 5 The treatment of this condition ranges from open surgery to endovascular therapy. Open repair with IMA resection and reimplantation has been considered the standard treatment, especially in cases in which maintenance of arterial supply by this vessel is mandatory, as in stenosis or superior mesenteric artery occlusion (high-flow aneurysms). 6 In turn, when the risks of a transperitoneal surgical approach are high, with the possibility of injury to adjacent structures, endovascular treatment may be an option. However, it is necessary to make sure that colonic perfusion can be adequately supplied by the Riolan arc and the marginal artery of Drummond. 7 Embolization with the implantation of coils into the lumen of the aneurysm is one possible treatment; however, a covered stent, provided it is adequately sized for the ostial caliber and extension of the IMA, is an option that preserves intestinal flow. Liquid agents may lead to inadvertent distal embolization, which is why their use is limited. Few cases of endovascular treatment have been described for IMAA to date. The objective of the study was to report a rare case of a carrier of multiple visceral aneurysms, one of which was a giant and symptomatic IMAA that was treated by transarterial embolization, and the long-term outcome. Written informed consent to publish the case and images was obtained from the patient. This report was approved by the research ethics committee of the Faculty of Medicine of Itajubá/Brazil, registered under Plataforma Brasil (No. 043567/2017).
CASE REPORT
A 59-year-old woman, with no comorbidities, with a family history of aneurysmal disease (her father died of a ruptured thoracic aortic aneurysm) was referred to the vascular and endo- 
DISCUSSION
IMAAs are extremely rare. Until 2018, only 65 true IMAA cases had been published in the English-language medical literature; patients ranged in age from 9 to 84 years, and 51 men and 14 women have been affected. 4, [7] [8] [9] [10] [11] [12] [13] However, no reported case presented with the dimensions described here. With the great availability of Doppler ultrasound, CT angiography, magnetic resonance imaging, and arteriography, many VAAs are being identified during investigations of abdominal pain or gastrointestinal bleeding, although most diagnosed cases are asymptomatic.
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In the case described here, in the 2-year follow-up, it was observed that despite the large amount of aneurysm mural thrombus, there was a considerable volume reduction (57%). This fact makes the increasing use of embolization without aneurysmal resection promising for the treatment of aneurysms with a mild to moderate mass effect. However, there has been no description in the literature of the rate of volume reduction after embolization of IMAAs. In addition, if the anatomy is favorable, the minimally invasive treatment may reduce the length of hospital stay and the risk of injury to adjacent organs.
In the case of large-volume aneurysms, we consider that CT angiography is the best option to detect volume reduction or recanalization. We believe that Doppler ultrasound may be a useful tool for monitoring minor aneurysms. Conducting examinations every 6 months in the first year and yearly thereafter appears to be reasonable and should be performed until stabilization of the aneurysm size.
The patient in question had multiple aneurysmal dilations in several visceral segments. Although most of the reported cases are of atherosclerotic origin, other causes should be addressed, such as neurofibromatosis, 16 mycotic aneurysms including endocarditis, 17 vascular Ehlers-Danlos syndrome, 18 polyarteritis nodosa, Behçet disease, 19 mutation in the SMAD3 gene, 20 and transforming growth factor b receptor mutations.
Fig 3.
Computed tomography (CT) angiography 2 years after the embolization procedure, in axial view, revealing an overall decrease in the dimensions of the inferior mesenteric artery aneurysm (IMAA).
